These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3715197)

  • 1. Time course of the binding of platinum to subfractions of the kidney cytosol in the cisplatin-treated rat.
    Mason R; Hogg S; Edwards IR
    Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):51-8. PubMed ID: 3715197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of Pt in the urine and kidney of the cisplatin treated rat.
    Mason RW; Hogg SJ; Edwards IR
    Toxicology; 1986 Feb; 38(2):219-26. PubMed ID: 3945972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of platinum with metallothionein-like ligands in the rat kidney after administration of cis-dichlorodiammine platinum II.
    Mason R; Edwards IR; McLaren SJ
    Chem Biol Interact; 1984 Apr; 49(1-2):165-76. PubMed ID: 6539175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covalent binding of platinum to renal protein from sensitive and resistant guinea pigs treated with cisplatin: possible role in nephrotoxicity.
    Litterst CL; Schweitzer VG
    Res Commun Chem Pathol Pharmacol; 1988 Jul; 61(1):35-48. PubMed ID: 3175342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplacental passage of Pt after treatment with the new triamine complex cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N4]-chloride platinum (II) monohydrochloride monohydrate.
    Ognio E; Chiavarina B; Caviglioli G; Lapide M; Viale M
    Arch Toxicol; 2004 Oct; 78(10):584-8. PubMed ID: 15150682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platinum accumulation in the kidney and liver following chemotherapy with cisplatin in humans.
    Uozumi J; Ueda T; Yasumasu T; Koikawa Y; Naito S; Kumazawa J; Sueishi K
    Int Urol Nephrol; 1993; 25(3):215-20. PubMed ID: 8225820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of cis-platinum with cellular zinc and copper in rat liver and kidney tissues.
    Sharma RP
    Pharmacol Res Commun; 1985 Feb; 17(2):197-206. PubMed ID: 4039454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance size-exclusion chromatography of 63Ni-constituents in renal cytosol and microsomes from 63NiCl2-treated rats.
    Sunderman FW; Mangold BL; Wong SH; Shen SK; Reid MC; Jansson I
    Res Commun Chem Pathol Pharmacol; 1983 Mar; 39(3):477-92. PubMed ID: 6856950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of cis-platinum nephrotoxicity: I. Effects of sulfhydryl groups in rat kidneys.
    Levi J; Jacobs C; Kalman SM; McTigue M; Weiner MW
    J Pharmacol Exp Ther; 1980 Jun; 213(3):545-50. PubMed ID: 7193725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cis-Diamminedichloroplatinum (II)-DNA adduct formation in renal, gonadal, and tumor tissues of male and female rats.
    Reed E; Litterst CL; Thill CC; Yuspa SH; Poirier MC
    Cancer Res; 1987 Feb; 47(3):718-22. PubMed ID: 3802077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal handling of cis-diamminedichloroplatinum(II).
    Jacobs C; Kalman SM; Tretton M; Weiner MW
    Cancer Treat Rep; 1980; 64(12):1223-6. PubMed ID: 7193518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of cisplatin nephrotoxicity.
    Weiner MW; Jacobs C
    Fed Proc; 1983 Oct; 42(13):2974-8. PubMed ID: 6684595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of cisplatin nephrotoxicity by procainamide: does the formation of a cisplatin-procainamide complex play a role?
    Viale M; Vannozzi MO; Pastrone I; Mariggiò MA; Zicca A; Cadoni A; Cafaggi S; Tolino G; Lunardi G; Civalleri D; Lindup WE; Esposito M
    J Pharmacol Exp Ther; 2000 Jun; 293(3):829-36. PubMed ID: 10869382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative gold-binding capacity of metallothionein: studies in renal cytosols of gold-injected rats.
    Saito S; Kojima Y
    Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):119-26. PubMed ID: 8733833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of cis-dichlorodiammine platinum (II) in patients undergoing hemodialysis].
    Miyakawa M; Sugimoto K; Ohe Y; Masuoka H; Miyahara T
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2491-5. PubMed ID: 3619461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro studies on cisplatin focusing on kinetic aspects of intracellular chemistry by LC-ICP-MS.
    Hermann G; Heffeter P; Falta T; Berger W; Hann S; Koellensperger G
    Metallomics; 2013 Jun; 5(6):636-47. PubMed ID: 23487031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cis-Platinum: subcellular distribution and binding to cytosolic ligands.
    Sharma RP; Edwards IR
    Biochem Pharmacol; 1983 Sep; 32(18):2665-9. PubMed ID: 6313005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term consequences of cis-platinum-induced renal injury: a structural and functional study.
    Dobyan DC
    Anat Rec; 1985 Jul; 212(3):239-45. PubMed ID: 4061878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin-induced toxicity is associated with platinum deposition in mouse kidney mitochondria in vivo and with selective inactivation of the alpha-ketoglutarate dehydrogenase complex in LLC-PK1 cells.
    Zhang L; Cooper AJ; Krasnikov BF; Xu H; Bubber P; Pinto JT; Gibson GE; Hanigan MH
    Biochemistry; 2006 Jul; 45(29):8959-71. PubMed ID: 16846239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.